zolpidem tartrate
Showing 1 - 25 of 228
Spine Fusion, Lumbar Spine Degeneration, Pain, Postoperative Trial in Los Angeles (Zolpidem Tartrate 10 mg, Placebo)
Recruiting
- Spine Fusion
- +3 more
- Zolpidem Tartrate 10 mg
- Placebo
-
Los Angeles, CaliforniaKeck Medical Center of USC
Feb 22, 2023
Insomnia, Insomnia Chronic Trial in Philadelphia (Zolpidem tartrate)
Recruiting
- Insomnia
- Insomnia Chronic
- Zolpidem tartrate
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 15, 2022
Healthy Trial in Pittsburgh, Houston (Zolpidem 10 mg tablets, AMBIEN® 10 mg tablets)
Completed
- Healthy
- Zolpidem 10 mg tablets
- AMBIEN® 10 mg tablets
-
Pittsburgh, Pennsylvania
- +1 more
Oct 6, 2020
Insomnia Disorders Trial in Toronto (Zolpidem tablets, Suvorexant tablets, over-encapsulated, Lemborexant tablets)
Completed
- Insomnia Disorders
- Zolpidem tablets
- +5 more
-
Toronto, CanadaINC Research Toronto, Inc.
Jun 26, 2020
Sleep Disturbance, Heart Failure Trial in Baltimore (Zolpidem Tartrate, Placebo oral capsule)
Completed
- Sleep Disturbance
- Heart Failure
- Zolpidem Tartrate
- Placebo oral capsule
-
Baltimore, MarylandJohns Hopkins Bayview Campus, Asthma and Allergy Center
Feb 10, 2020
Healthy Trial in Mumbai (Zolpidem Tartrate Tablets 10 mg, 'Sanofi-Synthelabo Inc's Ambien® Tablets 10 mg)
Completed
- Healthy
- Zolpidem Tartrate Tablets 10 mg
- 'Sanofi-Synthelabo Inc's Ambien® Tablets 10 mg
-
Mumbai, Maharashtra, IndiaAccutest Research Laboratories Pvt. Ltd.
May 1, 2018
Alcohol Use Disorder Trial in Houston (Lemborexant 10 mg, Naltrexone)
Not yet recruiting
- Alcohol Use Disorder
- Lemborexant 10 mg
- Naltrexone
-
Houston, TexasThe Menninger Clinic
Aug 11, 2022
Autism, Autism Spectrum Disorder Trial (Zolpidem, Placebo)
Not yet recruiting
- Autism
- Autism Spectrum Disorder
- Zolpidem
- Placebo
- (no location specified)
Sep 12, 2022
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
Healthy Non-dependent, Recreational Sedative Users, Abuse Potential Trial in Overland Park, Montreal (Suvorexant, Zolpidem,
Recruiting
- Healthy Non-dependent, Recreational Sedative Users
- Abuse Potential
- Suvorexant
- +3 more
-
Overland Park, Kansas
- +1 more
Jan 31, 2023
Iron-deficiency Trial in New Farm (Low dose IHAT, High Dose IHAT, Carob flour)
Not yet recruiting
- Iron-deficiency
- Low dose IHAT
- +2 more
-
New Farm, Queensland, AustraliaRDC Clinical Pty Ltd
Jul 14, 2023
Ocular Redness Trial in United States (Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify®
Recruiting
- Ocular Redness
- Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
- Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
-
Colorado Springs, Colorado
- +5 more
Oct 3, 2022
ZOlpidem and the stRengthening of pRescription regulatiOn
Completed
- Substance Use Disorders
- No interventional study
-
Nantes, Loire-Atlantique, FranceNantes University Hospital
Jan 3, 2022
Insomnia Trial in Guangzhou (Experimental group: Shugan Jieyu Capsule combined with zolpidem, Control group: Placebo combined
Recruiting
- Insomnia
- Experimental group: Shugan Jieyu Capsule combined with zolpidem
- Control group: Placebo combined with zolpidem
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Feb 28, 2023
Chronic Insomnia Trial in São Paulo (Sublingual Tablet)
Not yet recruiting
- Chronic Insomnia
- Sublingual Tablet
-
São Paulo, SP, BrazilInvestigational Site
Aug 5, 2022
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Healthy Trial in Basel (Lysergic Acid Diethylamide Base oral drinking solution, Lysergic Acid Diethylamide Base solid
Recruiting
- Healthy
- Lysergic Acid Diethylamide Base oral drinking solution
- +4 more
-
Basel, SwitzerlandClinical Pharmacology & Toxicology, University Hospital Basel
Mar 30, 2022
COVID-19 Virus Infection Trial in Salvador (LCLT : 68% elemental L-carnitine and 32 % Tartric acid, Placebo)
Completed
- COVID-19 Virus Infection
- LCLT : 68% elemental L-carnitine and 32 % Tartric acid
- Placebo
-
Salvador, Bahia, BrazilSenai Cimatec
Jun 30, 2022
Helicobacter Pylori Infection Trial in Changsha (Group1 Vonoprazan Fumarate + amoxicillin + doxycycline, Group2 Vonoprazan
Recruiting
- Helicobacter Pylori Infection
- Group1 Vonoprazan Fumarate + amoxicillin + doxycycline
- +3 more
-
Changsha, Hunan, ChinaThe third Xiangya Hospital of central south University
Feb 2, 2022
Dry Eye Trial in United States (Brimonidine Tartrate, Placebos)
Completed
- Dry Eye
- Brimonidine Tartrate
- Placebos
-
Newport Beach, California
- +15 more
Jun 29, 2022
Sleep-disordered Breathing Trial in Detroit (Zolpidem, No Treatment)
Completed
- Sleep-disordered Breathing
- Zolpidem
- No Treatment
-
Detroit, MichiganJohn D. Dingell VA Medical Center
Apr 2, 2022